NewsBenzingaInnate Pharma 9个月营收340万欧元，同比为230万欧元；现金9680万欧元；首席财务官弗雷德里克·隆巴尔将于12月31日离任 Innate Pharma 9个月营收340万欧元，同比为230万欧元；现金9680万欧元；首席财务官弗雷德里克·隆巴尔将于12月31日离任 Benzinga 2026.11.05 07:52 (GMT+0) Open on Benzinga Other news Avalo Therapeutics Files Prospectus For Offering Mixed Shelf; Terms Undisclosed Wells Fargo CIB CEO Fernando Rivas Says Our Corporate Investment Banking Pipelines Are At An All-Time High Lipocine Q3 EPS $(0.08) Beats $(0.32) Estimate, Sales $2.290M Beat $159.500K Estimate McDonald's To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Thursday Susquehanna Maintains Positive on GATX, Raises Price Target to $220 SCYNEXIS Q3 EPS $(0.71) Beats $(0.72) Estimate
Wells Fargo CIB CEO Fernando Rivas Says Our Corporate Investment Banking Pipelines Are At An All-Time High
